Integragen

Integragen Dividend

Dividend of Integragen (ALINT.PA) as of Nov 8, 2026.

Dividend

0.00EUR

Last updated:

How much dividend does Integragen 2026 pay?

According to the latest status from November 2026, Integragen paid a total of 0.00 EUR per share in dividends within the last 12 months. With the current Integragen price of 0.08 EUR, this corresponds to a dividend yield of - %. A dividend is paid times per year.

Historical Integragen Dividends

Historical Integragen Dividends
PaydateDividend

The Integragen Dividend history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Dividend
Date
Dividend
Jan 1, 2023
0.00 EUR
Jan 1, 2024
0.00 EUR
Jan 1, 2025
0.00 EUR
Jan 1, 2026 (e)
0.00 EUR
Jan 1, 2027 (e)
0.00 EUR
Jan 1, 2028 (e)
0.00 EUR
Jan 1, 2029 (e)
0.00 EUR
Jan 1, 2030 (e)
0.00 EUR
The Integragen Dividend history
YEARDividendYoY
est0.00EUR—
est0.00EUR—
est0.00EUR—
est0.00EUR—
est0.00EUR—
0.00EUR—
0.00EUR—
0.00EUR—
0.00EUR—
0.00EUR—
0.00EUR—
0.00EUR—
0.00EUR—
0.00EUR—
0.00EUR—
0.00EUR—
0.00EUR—
0.00EUR—
0.00EUR—
0.00EUR—
0.00EUR—
0.00EUR—
0.00EUR—
0.00EUR—

Is the Integragen Dividend Safe?

Integragen has been increasing the dividend for 0 years.

Analysts expect a Dividend Cut of -100.00% for the current fiscal year.

Dividend Details

Understanding Integragen's Dividend Distributions

Integragen’s dividends are a portion of the company’s profits distributed to shareholders. It is a critical indicator of the company’s financial health and attractiveness to investors. Dividends provide investors with a steady income stream, in addition to any profits that may come from selling the stock at a higher price than the purchase price.

Year-to-Year Comparison

Examining Integragen's dividend distributions over the years can highlight the company’s profitability and stability. A consistent or increasing dividend payout can indicate a financially healthy company with predictable earnings, while fluctuations or reductions in dividends can suggest underlying financial or operational challenges.

Impact on Investments

Integragen's dividend payments are an essential factor for income-focused investors. A robust dividend payout can enhance the stock’s appeal, offering regular income in addition to potential capital gains. It also can indicate the company's confidence in its future earnings, making it a significant consideration in investment decisions.

Interpreting Dividend Fluctuations

Changes in Integragen’s dividends can result from shifts in the company’s earnings, financial policies, or reinvestment strategies. An increase in dividends often signals financial stability, while a decrease may indicate a need to conserve cash or reinvest profits to fuel growth, each scenario having different implications for investors.

Integragen Stock analysis

What does Integragen do? IntegraGen SA is a French biotechnology company based in Evry. It was founded in 2000 and is one of the leading companies in developing commercial applications in genomics and biology. The business model of IntegraGen SA consists of providing solutions and services for the diagnosis and treatment of various diseases, such as cancer, neurodegenerative diseases, and other genetically related diseases. The company is divided into two main areas: Diagnostics and Genomics. The Diagnostics area offers a wide range of services to its customers, including an oncology platform for the diagnosis and prediction of cancer using exclusive biomarker sets. Other diagnostic tests are used for the identification of microorganisms in clinical samples and the detection of autoimmune diseases. In the Genomics area, the focus is on the development and sale of PCR kits for genotyping single nucleotide polymorphisms (SNPs) and analysis kits for RNA expression. These solutions allow for the identification and validation of genes in specific biological samples in a way that improves customers' understanding and enables accurate findings. IntegraGen SA is committed to continuously developing new tests and platforms to help its customers achieve more precise diagnoses and better therapies. One notable development of the company is the screening kit "Arisk," which is specifically designed for identifying genotypes that have an increased risk of colorectal cancer. The screening kit uses specific SNPs to ensure that doctors can identify patients who require increased monitoring or even prophylactic surgery. The use of genomics technology and biomarker-based diagnostics is a growing trend in medicine. IntegraGen SA plays a significant role in enabling the integration of genomics into clinical practice, ensuring the best possible diagnosis and treatment for patients. In summary, IntegraGen SA is an innovative biotechnology company dedicated to providing solutions for the diagnosis and prevention of diseases using various technologies. The company is constantly striving to develop new products and services to provide customers and partners with the best possible diagnostic and therapeutic support. Integragen is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Integragen stock

Integragen paid dividends every year for the past 0 years.

Integragen is assigned to the 'Health' sector.

The dividends of Integragen are distributed in EUR.

Dividend calendar 2026

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

All Key Metrics — Integragen